Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAPZA1P5 (“CAPZA1 pseudogene 5”) is a human genomic locus classified as a pseudogene related to the protein-coding gene CAPZA1, which encodes the alpha subunit of the barbed-end actin capping protein. Pseudogenes such as CAPZA1P5 are non-functional DNA sequences that resemble known genes but typically do not encode proteins and do not participate in recognized molecular or therapeutic pathways. In contrast, CAPZA1 is a well-characterized cytoskeletal protein involved in stabilizing actin filaments and regulating their growth by capping the barbed end. CAPZA1 has established roles in cellular architecture, actin filament dynamics, and disease progression, including certain cancers and muscular disorders. CAPZA1P5 itself has no described biological function, disease relevance, drug interaction profile, or safety concerns, and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capping protein (actin filament) muscle Z-line, alpha 1 pseudogene 5 (CAPZA1P5).